Neoplasms Metastasis Withdrawn Phase 1 Trials for Tetrahydrouridine (DB12484)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02839694Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary MetastasectomyTreatment